Washington Post Reports on Hemophilia B Gene Therapy Advance

Published on in CHOP News

CHOP hematologist Lindsey George, MD, the lead investigator of a clinical trial of a gene therapy for hemophilia B, spoke to the Washington Post about how the experimental treatment allowed patients to avoid painful, disabling internal bleeds.

Read the article